造影超音波市場：製品,技術,供給方式,イメージング技術,用途,患者属性,エンドユーザー別-2025-2030年世界予測

造影超音波市場は、2023年に20億8,000万米ドルと評価され、2024年には22億米ドルに達すると予測され、CAGR 6.43%で成長し、2030年には32億1,000万米ドルになると予測されています。

造影超音波（CEUS）は、造影剤を使用して超音波画像の鮮明さと細部を改善することにより、従来の超音波検査を強化する強力なイメージング技術です。このモダリティは、非侵襲的な性質、リアルタイムの撮像機能、電離放射線を使用しないこと、微小血管の血流変化を検出する精度が向上していることなどから、医療診断において重要な位置を占めています。CEUSの必要性は、主に肝臓病変の検出、複雑な腹部腫瘤の特徴判定、臓器灌流の評価といった診断的応用から生じ、臨床的意思決定を強化します。CEUSの最終用途は病院、診療所、画像診断センターなど多岐にわたり、そこでは正確な診断と患者の安全が最優先されます。

CEUSの市場成長は、肝疾患や心血管疾患の増加、非侵襲的診断法の利点に関する意識の高まり、超音波システムの技術進歩など、さまざまな要因によって後押しされています。最近の潜在的なビジネスチャンスは、腫瘍評価のための腫瘍学や心臓病診断向上のための心血管系評価など、従来の領域を超えたCEUS応用の拡大にあります。このようなビジネスチャンスを生かすためには、費用対効果が高く患者に優しい造影剤と超ポータブル超音波診断装置を革新するための研究開発投資が必要です。

しかし、CEUS市場は、造影剤が比較的高価であること、訓練された専門家が不足していること、特定の地域における造影剤の承認に関する規制上の課題などの制約に直面しています。これらの要因は、MRIやCTのような代替画像モダリティとの競合と相まって、市場成長の課題となっています。イノベーションの機会としては、より高度な画像解析のためのAI駆動型ソフトウェアの開発、ポイント・オブ・ケア・シナリオに対応した超音波診断装置の小型化、獣医療におけるCEUS応用の模索などが挙げられます。

全体として、CEUS市場は大きな成長の可能性を秘めたダイナミックな市場です。競争力を維持するために、利害関係者は技術的進歩を優先し、応用分野を拡大し、費用対効果を改善することで、多様な医療分野での幅広い採用を確保すべきです。

市場力学：急速に進化する造影超音波市場の主要市場インサイトを公開

造影超音波市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患および生活習慣病の有病率の上昇
  • 非侵襲的診断法への嗜好の高まり
• 市場抑制要因
  • 既存の医療インフラへのCEUの統合と展開の問題
• 市場機会
  • 造影超音波の精度向上のための画像技術の絶え間ない革新
  • 患者に合わせた治療のための個別化診断プロトコルの高い可能性
• 市場の課題
  • 診断のための代替技術の利用可能性

ポーターの5つの力：造影超音波市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：造影超音波市場における外部からの影響の把握

外部マクロ環境要因は、造影超音波市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析造影超音波市場における競合情勢の把握

造影超音波市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス造影超音波市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、造影超音波市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨造影超音波市場における成功への道筋を描く

造影超音波市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患および生活習慣病の罹患率の上昇
    • 非侵襲的診断手順に対する好みの増加
  • 抑制要因
    • 既存の医療インフラへのCEUの統合と展開の問題
  • 機会
    • 造影超音波の精度を向上させるための画像技術の継続的な革新
    • よりカスタマイズされた患者ケアのための個別診断プロトコルの高い可能性
  • 課題
    • 診断のための代替技術の利用可能性
• 市場セグメンテーション分析
  • 製品：イメージング機能の向上によるマイクロバブル造影剤の新たな利用
  • 応用：血流を可視化できるため、心臓血管画像診断におけるCEUSの応用が拡大しています。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 造影超音波市場：製品別

• 造影剤
  • マイクロバブル造影剤
  • ナノ粒子ベースの造影剤
• 超音波装置

第7章 造影超音波市場：技術別

• 2D超音波
• 3Dおよび4D超音波

第8章 造影超音波市場配送方法別

• 血管内
• 膀胱内

第9章 造影超音波市場イメージング技術別

• 固定小数点または静的
• リアルタイム

第10章 造影超音波市場：用途別

• 腹部画像
• 心臓血管画像診断
• 筋骨格画像
• 産科および婦人科画像診断
• 泌尿器科画像診断

第11章 造影超音波市場患者層別

• 成人画像診断
• 老年画像診断
• 小児画像診断

第12章 造影超音波市場：エンドユーザー別

• クリニック
• 画像診断センター
• 病院
• 調査機関

第13章 南北アメリカの造影超音波市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第14章 アジア太平洋地域の造影超音波市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第15章 欧州・中東・アフリカの造影超音波市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第16章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 造影超音波の教育と基準の向上に向けたInteleosと国際造影超音波学会の協力
  • サムスンメディソンとブラッコイメージングが提携し、診断用超音波技術の進歩を目指す
  • Koninklijke Philips N.VはEPIQ Eliteのアプリケーションを強化しました
• 戦略分析と提言

企業一覧

• Bracco S.p.A.
• Bristol-Myers Squibb Company
• Canon Inc.
• Carestream Health, Inc.
• Daiichi Sankyo Company, Limited
• Esaote S.p.A,
• FUJIFILM Corporation
• GE HealthCare Technologies Inc.
• Hitachi, Ltd.
• Koninklijke Philips N.V.
• Lantheus Holdings, Inc.
• Leriva SA
• Mayo Clinic
• Medtronics PLC
• Mobisante, Inc.
• nanoPET Pharma GmbH
• Samsung Medison Co., Ltd.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Siemens AG
• TeraRecon, Inc.
• Toshiba Corporation
• Trivitron Healthcare Private Limited

LIST OF FIGURES

• FIGURE 1. CONTRAST ENHANCED ULTRASOUND MARKET RESEARCH PROCESS
• FIGURE 2. CONTRAST ENHANCED ULTRASOUND MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 19. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 23. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 28. CONTRAST ENHANCED ULTRASOUND MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 29. CONTRAST ENHANCED ULTRASOUND MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CONTRAST ENHANCED ULTRASOUND MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CONTRAST ENHANCED ULTRASOUND MARKET DYNAMICS
• TABLE 7. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MICROBUBBLE CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY NANOPARTICLE-BASED CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ULTRASOUND MACHINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY 3D & 4D ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVASCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY INTRAVESICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY FIXED-POINT OR STATIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY REAL-TIME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ABDOMINAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY OBSTETRIC & GYNECOLOGICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY UROLOGICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY ADULT IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY GERIATRIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PEDIATRIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 64. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 66. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 67. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 69. CANADA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 77. MEXICO CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 85. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 94. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 100. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 101. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 103. AUSTRALIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 106. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 108. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 109. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 111. CHINA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 114. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 116. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 117. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 119. INDIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 122. INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 124. INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 125. INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 127. INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. JAPAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. JAPAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 130. JAPAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. JAPAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 132. JAPAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 133. JAPAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. JAPAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 135. JAPAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. MALAYSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. MALAYSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 138. MALAYSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. MALAYSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 140. MALAYSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 141. MALAYSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. MALAYSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 143. MALAYSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. PHILIPPINES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. PHILIPPINES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 146. PHILIPPINES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. PHILIPPINES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 148. PHILIPPINES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 149. PHILIPPINES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. PHILIPPINES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 151. PHILIPPINES CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 154. SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 156. SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 157. SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 159. SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 170. TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 172. TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 173. TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 175. TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. THAILAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. THAILAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 178. THAILAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. THAILAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 180. THAILAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 181. THAILAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. THAILAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 183. THAILAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. VIETNAM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. VIETNAM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 186. VIETNAM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. VIETNAM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 188. VIETNAM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 189. VIETNAM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. VIETNAM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 191. VIETNAM CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 194. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 196. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 201. DENMARK CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. DENMARK CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 203. DENMARK CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 204. DENMARK CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 205. DENMARK CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 206. DENMARK CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. DENMARK CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 208. DENMARK CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. EGYPT CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. EGYPT CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 211. EGYPT CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. EGYPT CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 213. EGYPT CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 214. EGYPT CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. EGYPT CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 216. EGYPT CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. FINLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. FINLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 219. FINLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 220. FINLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 221. FINLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 222. FINLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. FINLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 224. FINLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 227. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 228. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 229. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 230. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 232. FRANCE CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 235. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 236. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 237. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 238. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 240. GERMANY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. ISRAEL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 242. ISRAEL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 243. ISRAEL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 244. ISRAEL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 245. ISRAEL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 246. ISRAEL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 247. ISRAEL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 248. ISRAEL CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 249. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 250. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 251. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 252. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 253. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 254. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 255. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 256. ITALY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 257. NETHERLANDS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 258. NETHERLANDS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 259. NETHERLANDS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 260. NETHERLANDS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 261. NETHERLANDS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 262. NETHERLANDS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 263. NETHERLANDS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 264. NETHERLANDS CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 265. NIGERIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 266. NIGERIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 267. NIGERIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 268. NIGERIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 269. NIGERIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 270. NIGERIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. NIGERIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 272. NIGERIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 273. NORWAY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 274. NORWAY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 275. NORWAY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 276. NORWAY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 277. NORWAY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 278. NORWAY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 279. NORWAY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 280. NORWAY CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 281. POLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 282. POLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 283. POLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 284. POLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 285. POLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 286. POLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 287. POLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 288. POLAND CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 289. QATAR CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 290. QATAR CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 291. QATAR CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 292. QATAR CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 293. QATAR CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 294. QATAR CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 295. QATAR CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 296. QATAR CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 297. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 298. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 299. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 300. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 301. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 302. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 303. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 304. RUSSIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 305. SAUDI ARABIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 306. SAUDI ARABIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 307. SAUDI ARABIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 308. SAUDI ARABIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 309. SAUDI ARABIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY IMAGING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 310. SAUDI ARABIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 311. SAUDI ARABIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 312. SAUDI ARABIA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 313. SOUTH AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 314. SOUTH AFRICA CONTRAST ENHANCED ULTRASOUND MARKET SIZE, BY CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 315. SOUTH AFRICA CONTRAST ENHA

The Contrast Enhanced Ultrasound Market was valued at USD 2.08 billion in 2023, expected to reach USD 2.20 billion in 2024, and is projected to grow at a CAGR of 6.43%, to USD 3.21 billion by 2030.

Contrast Enhanced Ultrasound (CEUS) stands as a powerful imaging technique that enhances conventional ultrasound by employing contrast agents to improve the clarity and detail of ultrasound images. This modality holds significant importance within medical diagnostics due to its non-invasive nature, real-time imaging capabilities, absence of ionizing radiation, and improved accuracy in detecting microvascular blood flow changes. The necessity for CEUS arises primarily from its diagnostic application in detecting liver lesions, characterizing complex abdominal masses, and evaluating organ perfusion, enhancing clinical decision-making. Its end-use scope spans hospitals, clinics, and diagnostic imaging centers, where accurate diagnoses and patient safety are paramount.

Market growth for CEUS is propelled by various factors, including increasing incidences of liver disorders and cardiovascular diseases, growing awareness regarding the benefits of non-invasive diagnostic procedures, and technological advancements in ultrasound systems. The latest potential opportunity lies in the expansion of CEUS applications beyond traditional domains, such as in oncology for tumor evaluation and cardiovascular assessments for improved heart disease diagnostics. For businesses to capitalize on these opportunities, they should invest in R&D to innovate cost-effective and patient-friendly contrast agents and ultra-portable ultrasound devices.

However, the CEUS market faces limitations such as the relatively high cost of contrast agents, a shortage of trained professionals, and regulatory challenges pertaining to the approval of contrast agents in certain regions. These factors, combined with competition from alternative imaging modalities like MRI and CT, pose challenges to market growth. Innovation opportunities exist in developing AI-driven software for enhanced image analysis, miniaturization of ultrasound devices for point-of-care scenarios, and exploring CEUS applications in veterinary medicine.

Overall, the CEUS market is dynamic with significant growth potential. To remain competitive, stakeholders should prioritize technological advancements, expand application areas, and improve cost-effectiveness, ensuring broader adoption across diverse medical disciplines.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Contrast Enhanced Ultrasound Market

The Contrast Enhanced Ultrasound Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of chronic and lifestyle-related diseases
  • Increasing preference for non-invasive diagnostic procedures
• Market Restraints
  • Integration and deployment issues of CEU into existing medical infrastructure
• Market Opportunities
  • Continuous innovation in imaging technologies to improve the accuracy of contrast-enhanced ultrasound
  • High potential in personalized diagnostic protocols for more tailored patient care
• Market Challenges
  • Availability of alternative technologies for diagnosis

Porter's Five Forces: A Strategic Tool for Navigating the Contrast Enhanced Ultrasound Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Contrast Enhanced Ultrasound Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Contrast Enhanced Ultrasound Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Contrast Enhanced Ultrasound Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Contrast Enhanced Ultrasound Market

A detailed market share analysis in the Contrast Enhanced Ultrasound Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Contrast Enhanced Ultrasound Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Contrast Enhanced Ultrasound Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Contrast Enhanced Ultrasound Market

A strategic analysis of the Contrast Enhanced Ultrasound Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Contrast Enhanced Ultrasound Market, highlighting leading vendors and their innovative profiles. These include Bracco S.p.A., Bristol-Myers Squibb Company, Canon Inc., Carestream Health, Inc., Daiichi Sankyo Company, Limited, Esaote S.p.A,, FUJIFILM Corporation, GE HealthCare Technologies Inc., Hitachi, Ltd., Koninklijke Philips N.V., Lantheus Holdings, Inc., Leriva SA, Mayo Clinic, Medtronics PLC, Mobisante, Inc., nanoPET Pharma GmbH, Samsung Medison Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, TeraRecon, Inc., Toshiba Corporation, and Trivitron Healthcare Private Limited.

Market Segmentation & Coverage

This research report categorizes the Contrast Enhanced Ultrasound Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Contrast Agents and Ultrasound Machines. The Contrast Agents is further studied across Microbubble Contrast Agents and Nanoparticle-Based Contrast Agents.
• Based on Technology, market is studied across 2D Ultrasound and 3D & 4D Ultrasound.
• Based on Mode of Delivery, market is studied across Intravascular and Intravesical.
• Based on Imaging Technique, market is studied across Fixed-Point or Static and Real-Time.
• Based on Application, market is studied across Abdominal Imaging, Cardiovascular Imaging, Musculoskeletal Imaging, Obstetric & Gynecological Imaging, and Urological Imaging.
• Based on Patient Demographics, market is studied across Adult Imaging, Geriatric Imaging, and Pediatric Imaging.
• Based on End-User, market is studied across Clinics, Diagnostic Imaging Centers, Hospitals, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of chronic and lifestyle-related diseases
    • 5.1.1.2. Increasing preference for non-invasive diagnostic procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Integration and deployment issues of CEU into existing medical infrastructure
  • 5.1.3. Opportunities
    • 5.1.3.1. Continuous innovation in imaging technologies to improve the accuracy of contrast-enhanced ultrasound
    • 5.1.3.2. High potential in personalized diagnostic protocols for more tailored patient care
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative technologies for diagnosis
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Emerging use of microbubble contrast agent due to enhanced imaging capabilities
  • 5.2.2. Application: Increasing applications of CEUS in cardiovascular imaging owing to its ability to visualize blood flow
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Contrast Enhanced Ultrasound Market, by Product

• 6.1. Introduction
• 6.2. Contrast Agents
  • 6.2.1. Microbubble Contrast Agents
  • 6.2.2. Nanoparticle-Based Contrast Agents
• 6.3. Ultrasound Machines

7. Contrast Enhanced Ultrasound Market, by Technology

• 7.1. Introduction
• 7.2. 2D Ultrasound
• 7.3. 3D & 4D Ultrasound

8. Contrast Enhanced Ultrasound Market, by Mode of Delivery

• 8.1. Introduction
• 8.2. Intravascular
• 8.3. Intravesical

9. Contrast Enhanced Ultrasound Market, by Imaging Technique

• 9.1. Introduction
• 9.2. Fixed-Point or Static
• 9.3. Real-Time

10. Contrast Enhanced Ultrasound Market, by Application

• 10.1. Introduction
• 10.2. Abdominal Imaging
• 10.3. Cardiovascular Imaging
• 10.4. Musculoskeletal Imaging
• 10.5. Obstetric & Gynecological Imaging
• 10.6. Urological Imaging

11. Contrast Enhanced Ultrasound Market, by Patient Demographics

• 11.1. Introduction
• 11.2. Adult Imaging
• 11.3. Geriatric Imaging
• 11.4. Pediatric Imaging

12. Contrast Enhanced Ultrasound Market, by End-User

• 12.1. Introduction
• 12.2. Clinics
• 12.3. Diagnostic Imaging Centers
• 12.4. Hospitals
• 12.5. Research Institutes

13. Americas Contrast Enhanced Ultrasound Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Contrast Enhanced Ultrasound Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Contrast Enhanced Ultrasound Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2023
• 16.2. FPNV Positioning Matrix, 2023
• 16.3. Competitive Scenario Analysis
  • 16.3.1. Collaborative Efforts of Inteleos and International Contrast Ultrasound Society to Elevate Contrast-Enhanced Ultrasound Education and Standards
  • 16.3.2. Samsung Medison and Bracco Imaging Partnered to Advance Diagnostic Ultrasound Technologies
  • 16.3.3. Koninklijke Philips N.V enhanced the application of EPIQ Elite
• 16.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bracco S.p.A.
• 2. Bristol-Myers Squibb Company
• 3. Canon Inc.
• 4. Carestream Health, Inc.
• 5. Daiichi Sankyo Company, Limited
• 6. Esaote S.p.A,
• 7. FUJIFILM Corporation
• 8. GE HealthCare Technologies Inc.
• 9. Hitachi, Ltd.
• 10. Koninklijke Philips N.V.
• 11. Lantheus Holdings, Inc.
• 12. Leriva SA
• 13. Mayo Clinic
• 14. Medtronics PLC
• 15. Mobisante, Inc.
• 16. nanoPET Pharma GmbH
• 17. Samsung Medison Co., Ltd.
• 18. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 19. Siemens AG
• 20. TeraRecon, Inc.
• 21. Toshiba Corporation
• 22. Trivitron Healthcare Private Limited